Albertsons Companies Inc banner

Albertsons Companies Inc
NYSE:ACI

Watchlist Manager
Albertsons Companies Inc Logo
Albertsons Companies Inc
NYSE:ACI
Watchlist
Price: 18.14 USD -1.79%
Market Cap: $9.3B

Albertsons Companies Inc
Investor Relations

Albertsons Companies Inc., a revered name in the American retail landscape, began its journey in 1939 when Joe Albertson opened a modest grocery store in Boise, Idaho. Fast forward to the present, and Albertsons has matured into one of the largest food and drug retailers in the United States, operating under 20 well-known banners, including Safeway, Vons, Jewel-Osco, and Acme. The company navigates the competitive grocery sector by blending brick-and-mortar presence with burgeoning digital initiatives. The stores are thoughtfully located in neighborhood settings, not only serving as grocery outlets but also becoming integral parts of their communities by offering pharmacy, fuel, and other related services. This extensive network is supported by a supply chain infrastructure meticulously designed to ensure consistent product availability and satisfy the needs of both urban and rural populations.

Albertsons generates revenue by leveraging its wide array of products ranging from everyday groceries to pharmacy offerings and ready-to-eat meals. Its robust private label portfolio further diversifies income streams by offering customers quality products at attractive prices, bolstering margins where traditional brands might cost more. The company's technological investments have enhanced its e-commerce capabilities, enabling the launch of initiatives like online ordering and home delivery. This digital transformation allows Albertsons to cater to changing consumer preferences and meet the demand for convenience, a trend accelerated by recent global events. By striking a balance between tradition and innovation, Albertsons not only sustains its competitive edge in the crowded grocery market but also strategically positions itself for future growth.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q3 2026
Call Date
Jan 7, 2026
AI Summary
Q3 2026

ID Sales Growth: Identical sales rose 2.4% in Q3, reflecting resilience despite headwinds from a government shutdown and SNAP delays.

Digital Acceleration: Digital sales jumped 21%, with penetration reaching 9.5%, highlighting successful investments in technology and AI.

Pharmacy Strength: Pharmacy and health sales increased 18%, boosted by immunizations, GLP-1 therapies, and core prescriptions.

Profitability & Cost Control: Adjusted EBITDA reached $1.039 billion and SG&A expense rate declined by 33 bps YoY, showing effective cost management.

Guidance Narrowed: Fiscal 2025 identical sales guidance narrowed to 2.2%–2.5% (down due to the Inflation Reduction Act), with adjusted EBITDA guided to $3.825–$3.875 billion and EPS to $2.08–$2.16.

Loyalty Growth: Loyalty membership grew 12% to 49.8 million, driving deeper engagement and higher customer value.

AI & Productivity: Management emphasized company-wide AI initiatives and expects $1.5 billion in productivity gains over three years.

Macro Caution: Consumer environment remains pressured, especially among low- and middle-income shoppers, prompting targeted promotions and price investments.

Key Financials
Identical Sales
2.4%
Digital Sales Growth
21%
Digital Penetration
9.5%
Pharmacy and Health Sales Growth
18%
Adjusted EBITDA
$1.039B
Adjusted EPS
$0.72 per diluted share
Gross Margin
27.4%
SG&A Expense Rate
24.9%
Interest Expense
$116M
Loyalty Membership
49.8 million
Capital Expenditures
$462M (Q3)
Net Debt to Adjusted EBITDA
2.29x
Quarterly Dividend
$0.15 per share
Accelerated Share Repurchase Program
$750M (announced, expected to complete early 2026)
Existing Share Repurchase Authorization Remaining
$1.3B
Other Earnings Calls

Management

Mr. Vivek Sankaran
CEO & Director
No Bio Available
Ms. Sharon L. McCollam CPA
President & CFO
No Bio Available
Mr. Thomas Michael Moriarty
Chief Policy Officer, Executive VP & General Counsel
No Bio Available
Mr. Robert B. Larson
Senior VP & Chief Accounting Officer
No Bio Available
Ms. Melissa C. Plaisance
SVP, Investor Relations, Treasury & Risk Management
No Bio Available
Mr. Justin Ewing
Executive Vice President of Corporate Development & Real Estate
No Bio Available
Mr. Michael T. Theilmann
Executive VP and Chief Human Resources Officer
No Bio Available
Mr. Jim Perkins
Executive VP of Retail Operations & Special Projects and President of ACME & Eastern Divisions
No Bio Available
Mr. Mike Withers
President of Jewel-Osco Division
No Bio Available
Mr. Shane Dorcheus
Executive Vice President of Retail Operations
No Bio Available

Contacts

Address
IDAHO
Boise
250 E Parkcenter Blvd
Contacts